Stay updated with breaking news from Cipla Buyout. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute among the founders could potentially delay the deal until a consensus is reached on the valuation, according to sources cited by ET Now.
Torrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of rival company Cipla. Torrent is also engaged with Brookfield to raise $1-1.2 billion in mezzanine debt. The company's founders, the Sudhir and Samir Mehta family, are seeking to dilute equity and create a non-disposable undertaking (NDU) using their shares as collateral for loans.